A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
Picoplatin is a new platinum-based chemotherapy drug that has been studied in a variety of
cancers. Phase 1 and 2 studies have demonstrated that picoplatin may be effective in patients
whose cancer returns or does not improve after treatment with chemotherapy. In these studies,
picoplatin was administered intravenously. A capsule containing picoplatin has been
formulated. This study will investigate the activity of the oral capsule in humans.
Participants with advanced solid tumors will be enrolled.